← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Children'S Hospital Los Angeles
Los Angeles, CA
$112,381,554
Total funding
180
Grants
Funding over time
peak $30.7M · FY2005–25$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$101,716,051 · 158
DOD$9,711,457 · 14
NSF$954,046 · 4
AHRQ$0 · 1
CDC$0 · 2
FDA$0 · 1
By mechanism
R01$58,101,767 · 71
U01$14,319,581 · 5
P01$13,495,521 · 38
—$10,665,503 · 18
P50$5,194,564 · 7
R21$4,604,853 · 13
Investigators at Children'S Hospital Los Angeles
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
LUNG INJURY; RELATES TO REAL-TIME ENDOSCOPIC MONITORING OF SINCLE CELLS RESPIRATORY HEALTH IN LUNG$2,272,586
· FY2016 · Department of the Army
Biology and Therapy of High Risk Neuroblastoma$1,938,669
P01 · FY2005 · CA
GENE THERAPY USING HEMATOPOIETIC STEM CELLS$1,827,927
P01 · FY2005 · HL
Molecular Basis of Lung Morphogenesis Injury &Repair$1,821,933
P01 · FY2005 · HL
BIOLOGY AND THERAPY OF HIGH-RISK NEUROBLASTOMA$1,819,507
P01 · FY2004 · CA
BIOLOGY AND THERAPY OF HIGH-RISK NEUROBLASTOMA$1,800,324
P01 · FY2000 · CA
MOLECULAR BASIS OF LUNG MORPHOGENESIS INJURY AND REPAIR$1,799,118
P01 · FY2002 · HL
GENE THERAPY USING HEMATOPOIETIC STEM CELLS$1,777,260
P01 · FY2004 · HL
BIOLOGY AND THERAPY OF HIGH-RISK NEUROBLASTOMA$1,775,574
P01 · FY2003 · CA
BIOLOGY AND THERAPY OF HIGH-RISK NEUROBLASTOMA$1,768,480
P01 · FY2002 · CA
MOLECULAR BASIS OF LUNG MORPHOGENESIS INJURY AND REPAIR$1,762,548
P01 · FY2001 · HL
GENE EXPRESSION IN SARCOMAS OF CHILDHOOD AND ADOLESCENCE$1,747,375
U01 · FY2002 · CA
BIOLOGY AND THERAPY OF HIGH-RISK NEUROBLASTOMA$1,737,898
P01 · FY2001 · CA
GENE THERAPY USING HEMATOPOIETIC STEM CELLS$1,731,873
P01 · FY2003 · HL
Diagnostic and Prognostic Sarcoma Signatures$1,730,668
U01 · FY2005 · CA
MOLECULAR BASIS OF LUNG MORPHOGENESIS INJURY AND REPAIR$1,702,595
P01 · FY2000 · HL
HSC DIFFERENTIATION$1,577,448
P50 · FY2004 · HL
HSC DIFFERENTIATION$1,534,582
P50 · FY2003 · HL
HSC DIFFERENTIATION$1,492,969
P50 · FY2002 · HL
HSC DIFFERENTIATION$1,452,683
P50 · FY2001 · HL